188 related articles for article (PubMed ID: 9125179)
1. Hemoglobin is utilized by Candida albicans in the hyphal form but not yeast form.
Tanaka WT; Nakao N; Mikami T; Matsumoto T
Biochem Biophys Res Commun; 1997 Mar; 232(2):350-3. PubMed ID: 9125179
[TBL] [Abstract][Full Text] [Related]
2. The formin family protein CaBni1p has a role in cell polarity control during both yeast and hyphal growth in Candida albicans.
Li CR; Wang YM; De Zheng X; Liang HY; Tang JC; Wang Y
J Cell Sci; 2005 Jun; 118(Pt 12):2637-48. PubMed ID: 15914538
[TBL] [Abstract][Full Text] [Related]
3. Csa2, a member of the Rbt5 protein family, is involved in the utilization of iron from human hemoglobin during Candida albicans hyphal growth.
Okamoto-Shibayama K; Kikuchi Y; Kokubu E; Sato Y; Ishihara K
FEMS Yeast Res; 2014 Jun; 14(4):674-7. PubMed ID: 24796871
[TBL] [Abstract][Full Text] [Related]
4. Hyphal formation of Candida albicans is controlled by electron transfer system.
Watanabe T; Ogasawara A; Mikami T; Matsumoto T
Biochem Biophys Res Commun; 2006 Sep; 348(1):206-11. PubMed ID: 16876761
[TBL] [Abstract][Full Text] [Related]
5. Hemoglobin is an effective inducer of hyphal differentiation in Candida albicans.
Pendrak ML; Roberts DD
Med Mycol; 2007 Feb; 45(1):61-71. PubMed ID: 17325946
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of the growth system of Candida albicans in a host and the development of new antifungal material].
Watanabe T
Yakugaku Zasshi; 2003 Jul; 123(7):561-7. PubMed ID: 12875238
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the CaBIG1 gene reduces beta-1,6-glucan synthesis, filamentation, adhesion, and virulence in Candida albicans.
Umeyama T; Kaneko A; Watanabe H; Hirai A; Uehara Y; Niimi M; Azuma M
Infect Immun; 2006 Apr; 74(4):2373-81. PubMed ID: 16552067
[TBL] [Abstract][Full Text] [Related]
8. Use of the Porcine Intestinal Epithelium (PIE)-Assay to analyze early stages of colonization by the human fungal pathogen Candida albicans.
Wendland J; Hellwig D; Walther A; Sickinger S; Shadkchan Y; Martin R; Bauer J; Osherov N; Tretiakov A; Saluz HP
J Basic Microbiol; 2006; 46(6):513-23. PubMed ID: 17139615
[TBL] [Abstract][Full Text] [Related]
9. Relationship between cell morphology and intracellular potassium concentration in Candida albicans.
Watanabe H; Azuma M; Igarashi K; Ooshima H
J Antibiot (Tokyo); 2006 May; 59(5):281-7. PubMed ID: 16883777
[TBL] [Abstract][Full Text] [Related]
10. Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis.
Zheng X; Wang Y; Wang Y
EMBO J; 2004 Apr; 23(8):1845-56. PubMed ID: 15071502
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium.
Jayatilake JA; Samaranayake YH; Cheung LK; Samaranayake LP
J Oral Pathol Med; 2006 Sep; 35(8):484-91. PubMed ID: 16918600
[TBL] [Abstract][Full Text] [Related]
12. Immunodetection of CD45 epitopes on the surface of Candida albicans cells in culture and infected human tissues.
Monteagudo C; Lopez-Ribot JL; Murgui A; Casanova M; Chaffin WL; Martinez JP
Am J Clin Pathol; 2000 Jan; 113(1):59-63. PubMed ID: 10631858
[TBL] [Abstract][Full Text] [Related]
13. Candida albicans protein analysis during hyphal differentiation using an integrative HA-tagging method.
Lee KH; Jun S; Hur HS; Ryu JJ; Kim J
Biochem Biophys Res Commun; 2005 Nov; 337(3):784-90. PubMed ID: 16212935
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry of Candida albicans for investigations of surface marker expression and phagocytosis.
Warolin J; Essmann M; Larsen B
Ann Clin Lab Sci; 2005; 35(3):302-11. PubMed ID: 16081588
[TBL] [Abstract][Full Text] [Related]
15. Candida albicans protein kinase CaHsl1p regulates cell elongation and virulence.
Umeyama T; Kaneko A; Nagai Y; Hanaoka N; Tanabe K; Takano Y; Niimi M; Uehara Y
Mol Microbiol; 2005 Jan; 55(2):381-95. PubMed ID: 15659158
[TBL] [Abstract][Full Text] [Related]
16. Systemic infection following intravenous inoculation of mice with Candida albicans int1 mutant strains.
Bendel CM; Kinneberg KM; Jechorek RP; Gale CA; Erlandsen SL; Hostetter MK; Wells CL
Mol Genet Metab; 1999 Aug; 67(4):343-51. PubMed ID: 10444345
[TBL] [Abstract][Full Text] [Related]
17. From commensal to pathogen: stage- and tissue-specific gene expression of Candida albicans.
Hube B
Curr Opin Microbiol; 2004 Aug; 7(4):336-41. PubMed ID: 15288621
[TBL] [Abstract][Full Text] [Related]
18. Farnesol-mediated inhibition of Candida albicans yeast growth and rescue by a diacylglycerol analogue.
Uppuluri P; Mekala S; Chaffin WL
Yeast; 2007 Aug; 24(8):681-93. PubMed ID: 17583896
[TBL] [Abstract][Full Text] [Related]
19. Temperature-dependent surface expression of the beta-2-integrin analogue of Candida albicans and its role in adhesion to the human endothelium.
Würzner R; Langgartner M; Spötl L; Eder A; Bujdáková H; Schröppel K; Dierich MP
Exp Clin Immunogenet; 1996; 13(3-4):161-72. PubMed ID: 9165270
[TBL] [Abstract][Full Text] [Related]
20. LAAE-14, a new anti-inflammatory drug, increases the survival of Candida albicans-inoculated mice.
Lucas R; Villamón E; Payá M; Alves M; del Olmo E; Gozalbo D; Gil ML
FEMS Immunol Med Microbiol; 2004 Apr; 40(3):239-42. PubMed ID: 15039100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]